SpringWorks Therapeutics Inc (NAS:SWTX)
$ 41.48 -0.25 (-0.6%) Market Cap: 3.09 Bil Enterprise Value: 2.72 Bil PE Ratio: 0 PB Ratio: 5.79 GF Score: 38/100

SpringWorks Therapeutics Inc at Goldman Sachs Global Healthcare Conference Transcript

Jun 15, 2022 / 03:40PM GMT
Release Date Price: $20.97 (+3.35%)
Corinne Jenkins
Goldman Sachs - Analyst

And thank you for joining us at the 43rd Annual Goldman Sachs Global Healthcare Conference. This morning, I am pleased to welcome the team from SpringWorks. With us today we have Chief Executive Officer, Saqib Islam, and Chief Operating Officer, Badreddin Edris. Maybe with that, I'll turn it to you to provide a brief overview of the Company and then we'll jump into questions.

Saqib Islam
SpringWorks Therapeutics, Inc. - CEO

Sure. Thank you, Corinne, and thanks for having us here. So we are on the back of our R&D Day last week, actually been very excited to talk about what our mission is for the company, which is to serve patients with rare diseases and cancers and help them live longer, healthier lives. And so we talked about what that meant to us last week at our R&D Day.

And ultimately, we were able to lay out the progress we had in each of our segments -- in each of our segments both in rare tumors, in metastatic solid tumors and in multiple myeloma. And so I think that from our perspective, that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot